NICOLE SANTOS: Open Payments
NPI 1366169476 · LAGUNA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,027 in 71 payments from 28 companies in 2025. Trend: 2023 $1,986 · 2024 $2,034 · 2025 $2,027
Food & beverage: $2,027
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $388 |
| ABBVIE INC. | 8 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $162 |
| SANOFI-AVENTIS U.S. LLC | 5 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $123 |
| Mannkind Corporation | 7 | $117 |
| Novo Nordisk Inc | 5 | $115 |
| Corcept Therapeutics | 1 | $111 |
| Verity Pharmaceuticals Inc. | 4 | $90 |
| Lilly USA, LLC | 4 | $77 |
Products named: KRYSTEXXA, JARDIANCE, REPATHA, TZIELD, Kerendia, AFREZZA, Korlym, UBRELVY.
Industry payments across CA — which companies pay providers there.
